CASTLEFIELDS — All Prescriptions & Medications — Page 3
Practice Code: M83024 | STAFFORD, ST16 1BS
Showing results 101-150 of 620
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Lercanidipine hydrochloride | 360 | 15.8K | £1.6K | -41.7% ▼ |
| Senna | 359 | 26.4K | £639 | -40.3% ▼ |
| 359 | 417 | £497 | +62.9% ▲ | |
| Insulin aspart | 354 | 2,266 | £15.6K | -7.0% ▼ |
| Duloxetine hydrochloride | 353 | 15.3K | £2.3K | -44.5% ▼ |
| Levetiracetam | 353 | 47.4K | £6.7K | -22.9% ▼ |
| Tiotropium bromide | 348 | 5,593 | £9.2K | +14.5% ▲ |
| 348 | 229.6K | £2.9K | +31.9% ▲ | |
| Lactulose | 332 | 189.2K | £1.8K | +0.8% vs avg |
| Acetylcysteine | 323 | 10.5K | £1.8K | +351.8% ▲ |
| Sumatriptan succinate | 317 | 3,310 | £2.1K | -10.5% ▼ |
| Sacubitril/valsartan | 314 | 18.2K | £29.6K | +31.1% ▲ |
| Tirzepatide | 307 | 363 | £36.2K | +58.1% ▲ |
| Glyceryl trinitrate | 306 | 609 | £733 | +29.4% ▲ |
| Progesterone | 305 | 23.5K | £4.5K | -27.1% ▼ |
| Hyoscine butylbromide | 303 | 26.5K | £1.9K | +30.0% ▲ |
| Rivaroxaban | 300 | 12.2K | £8.2K | -51.0% ▼ |
| Phenoxymethylpenicillin (Penicillin V) | 298 | 28.8K | £1.1K | -2.8% ▼ |
| 298 | 36.5K | £1.6K | +127.4% ▲ | |
| Loperamide hydrochloride | 297 | 20.2K | £587 | +27.5% ▲ |
| Estradiol | 288 | 7,308 | £3.8K | +6.8% ▲ |
| Umeclidinium bromide/vilanterol | 287 | 319 | £9.9K | +47.2% ▲ |
| Warfarin sodium | 281 | 16.4K | £577 | -40.4% ▼ |
| Prochlorperazine maleate | 280 | 12.7K | £1.0K | +38.5% ▲ |
| 276 | 24.1K | £1.8K | +27.6% ▲ | |
| Mesalazine (Systemic) | 274 | 29.5K | £16.6K | +14.4% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 266 | 35.3K | £2.2K | +17.7% ▲ |
| Esomeprazole | 265 | 12.8K | £1.4K | -34.5% ▼ |
| Carbamazepine | 260 | 35.5K | £2.0K | -12.4% ▼ |
| Thiamine hydrochloride | 260 | 18.0K | £469 | -50.7% ▼ |
| Pantoprazole | 259 | 11.4K | £513 | -5.8% ▼ |
| Clarithromycin | 258 | 5,396 | £1.2K | +5.1% ▲ |
| Fluticasone propionate (Nasal) | 246 | 1,284 | £2.9K | +69.0% ▲ |
| Combined ethinylestradiol 30mcg | 243 | 21.8K | £1.3K | -12.5% ▼ |
| Empagliflozin | 242 | 8,456 | £10.5K | -61.3% ▼ |
| Topiramate | 240 | 17.3K | £2.1K | +35.0% ▲ |
| Linagliptin | 240 | 9,856 | £11.1K | -41.4% ▼ |
| Sodium valproate | 227 | 39.1K | £3.9K | -28.6% ▼ |
| Ferrous fumarate | 221 | 14.8K | £607 | -69.5% ▼ |
| Umeclidinium bromide | 219 | 284 | £7.4K | +255.3% ▲ |
| 217 | 2,115 | £799 | +3.8% ▲ | |
| Cyclizine hydrochloride | 215 | 10.8K | £425 | +33.3% ▲ |
| Pravastatin sodium | 213 | 9,828 | £438 | -34.4% ▼ |
| Biphasic insulin aspart | 211 | 1,518 | £9.0K | +107.8% ▲ |
| Trimethoprim | 209 | 4,422 | £315 | +2.3% ▲ |
| Paroxetine hydrochloride | 207 | 6,378 | £243 | +10.9% ▲ |
| Methotrexate | 207 | 5,296 | £369 | -36.4% ▼ |
| Bimatoprost | 207 | 2,838 | £2.5K | +39.3% ▲ |
| Melatonin | 206 | 12.7K | £4.0K | -38.1% ▼ |
| 205 | 1,842 | £1.1K | +100.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.